Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04383808 · ClinicalTrials.gov registry record · NA
Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR
A NA study of Brain Disease, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04383808: Recruiting NA study of Brain Disease, sponsored by Stanford University.
NCT04383808 is a NA study of Brain Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 737-participant average among 8 other Brain Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04383808, a NA study of Brain Disease, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a commercial whole-body permanently integrated PET/MRI system using a common radiopharmaceutical.
Primary Outcome
The key specific measurement is the resulting PET/MR image obtained from the single subject scan.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Injected radiotracer with PET Insert
- DIAGNOSTIC_TEST Pre-injected group with PET insert
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT04383808 shows while recruiting
NCT04383808 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 737-participant average among 8 other Brain Disease trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Brain Disease appearing as the primary indexed condition, and to 2 interventions - of which Injected radiotracer with PET Insert is the first listed.
NCT04383808 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04383808 about?
NCT04383808 is a clinical study titled "Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR". The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a com...
What is the current status of trial NCT04383808?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-01. Estimated completion is 2028-03-31.
What conditions does trial NCT04383808 study?
This clinical trial studies the following conditions: Brain Disease.
What interventions are being tested in trial NCT04383808?
The interventions under investigation include: Injected radiotracer with PET Insert (DIAGNOSTIC_TEST), Pre-injected group with PET insert (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04383808?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04383808 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04383808's enrollment target sits among peer trials
40 8th of 8 higher than 1 of 8 other Brain Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
-
Brain Connections for Arm Movement After Stroke
RECRUITING · NA
-
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
RECRUITING
-
Natural History of Stroke: Cause and Development
RECRUITING
-
Inflammatory and Infectious Diseases of the Nervous System
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI